JP2005514406A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005514406A5 JP2005514406A5 JP2003557275A JP2003557275A JP2005514406A5 JP 2005514406 A5 JP2005514406 A5 JP 2005514406A5 JP 2003557275 A JP2003557275 A JP 2003557275A JP 2003557275 A JP2003557275 A JP 2003557275A JP 2005514406 A5 JP2005514406 A5 JP 2005514406A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical formulation
- nitric oxide
- oxide donor
- stem cells
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34547802P | 2002-01-04 | 2002-01-04 | |
| PCT/US2003/000323 WO2003056899A2 (en) | 2002-01-04 | 2003-01-06 | Nitric oxide donors for treatment of disease and injury |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009181759A Division JP2009256374A (ja) | 2002-01-04 | 2009-08-04 | 疾患および損傷の処置のための一酸化窒素ドナー |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005514406A JP2005514406A (ja) | 2005-05-19 |
| JP2005514406A5 true JP2005514406A5 (https=) | 2009-09-24 |
| JP4545440B2 JP4545440B2 (ja) | 2010-09-15 |
Family
ID=23355218
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003557275A Expired - Fee Related JP4545440B2 (ja) | 2002-01-04 | 2003-01-06 | 疾患および損傷の処置のための一酸化窒素ドナー |
| JP2009181759A Pending JP2009256374A (ja) | 2002-01-04 | 2009-08-04 | 疾患および損傷の処置のための一酸化窒素ドナー |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009181759A Pending JP2009256374A (ja) | 2002-01-04 | 2009-08-04 | 疾患および損傷の処置のための一酸化窒素ドナー |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20050143388A1 (https=) |
| EP (1) | EP1469852A4 (https=) |
| JP (2) | JP4545440B2 (https=) |
| CN (1) | CN1638775A (https=) |
| AU (1) | AU2003210447B2 (https=) |
| CA (1) | CA2471147C (https=) |
| IL (1) | IL162850A0 (https=) |
| WO (1) | WO2003056899A2 (https=) |
| ZA (1) | ZA200405507B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007010337A2 (de) * | 2005-07-15 | 2007-01-25 | Proxomed Medizintechnik Gmbh | Verwendung von phosphodiesterase typ 5-hemmern für die prävention und behandlung von adipositas, sowie abgabesysteme für dieselben |
| WO2008020864A2 (en) * | 2005-11-14 | 2008-02-21 | The Trustees Of Columbia University In The City Of New York | Imaging correlates of neurogenesis with mri |
| US8841300B2 (en) | 2006-10-02 | 2014-09-23 | Jerry M. Held | Treatment for Parkinson's disease—combination high dose serotonergic synaptic reuptake inhibitor with phosphodiesterase inhibitor |
| CA2687679A1 (en) * | 2007-05-18 | 2008-11-27 | Vivus, Inc. | Novel compositions comprising a phosphodiesterase-5 inhibitor and their use in methods of treatment |
| WO2009046377A2 (en) * | 2007-10-04 | 2009-04-09 | Medistem Laboratories, Inc. | Compositions and methods of stem cell therapy for autism |
| WO2009059271A1 (en) * | 2007-11-02 | 2009-05-07 | University Of Miami | Diagnosis and treatment of cardiac disorders |
| MX361539B (es) | 2012-04-25 | 2018-12-10 | Takeda Pharmaceuticals Co | Compuesto heterociclico nitrogenado. |
| EP2873669A4 (en) | 2012-07-13 | 2015-11-25 | Takeda Pharmaceutical | HETEROCYCLIC CONNECTION |
| JP6338601B2 (ja) * | 2013-03-01 | 2018-06-06 | フンダシオン パラ ラ インベスティガシオン メディカ アプリカダ | ホスホジエステラーゼとヒストンデアセチラーゼの二重阻害剤としての新規な化合物 |
| EP2975031A4 (en) | 2013-03-14 | 2017-04-19 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| JP6427491B2 (ja) | 2013-07-03 | 2018-11-21 | 武田薬品工業株式会社 | 複素環化合物 |
| ES2950424T3 (es) | 2013-07-03 | 2023-10-09 | Takeda Pharmaceuticals Co | Compuesto de amida |
| US10297661B2 (en) * | 2017-06-30 | 2019-05-21 | Taiwan Semiconductor Manufacturing Co., Ltd. | High voltage resistor device |
| EP4450072A4 (en) * | 2021-12-14 | 2026-02-18 | Zhenao Jinyinhua Pharmaceutical | USE OF SILDENAFIL OR A SALT THEREOF IN THE PREPARATION OF A MEDICINE FOR THE PREVENTION OR TREATMENT OF ISCHEMIC BRAIN INJURY |
| TWI879058B (zh) * | 2023-08-31 | 2025-04-01 | 未來新藥股份有限公司 | Pde5抑制劑組合於促進神經突生長之新穎用途 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2224195A (en) * | 1994-04-15 | 1995-11-10 | Masaomi Iyo | Medicinal composition for treating tardive dyskinesia and utilization thereof |
| US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
| EP1006798A4 (en) * | 1996-09-05 | 2003-03-05 | Massachusetts Inst Technology | COMPOSITIONS AND METHODS FOR TREATING NEUROLOGICAL DISORDERS AND NEURODEGENERATIVE DISEASES |
| US6043223A (en) * | 1997-11-12 | 2000-03-28 | The Regents Of The University Of California | Enhanced opening of abnormal brain tissue capillaries |
| DE19834507A1 (de) * | 1998-07-31 | 2000-02-03 | Hexal Ag | Pharmazeutische, wasserlösliche Tablettenformulierung zur Anwendung von Sildenafil |
| JP2002544234A (ja) * | 1999-05-14 | 2002-12-24 | ヘンリー フォード ヘルス システム | 発作の処置のための骨髄移植 |
| IL147112A0 (en) * | 1999-06-14 | 2002-08-14 | Ford Henry Health System | Nitric oxide donors for inducing neurogenesis |
| US6075028A (en) * | 1999-09-23 | 2000-06-13 | Graham; Richard | Method of treating Tourette's syndrome and related CNS disorders |
| IL139073A0 (en) | 1999-10-21 | 2001-11-25 | Pfizer | Treatment of neuropathy |
| US6271228B1 (en) * | 2000-04-28 | 2001-08-07 | Pfizer Inc. | Blood pressure stabilization during hemodialysis |
| ATE526020T1 (de) * | 2000-08-10 | 2011-10-15 | Cold Spring Harbor Lab | Gesteigertes kognitives training |
-
2003
- 2003-01-06 WO PCT/US2003/000323 patent/WO2003056899A2/en not_active Ceased
- 2003-01-06 AU AU2003210447A patent/AU2003210447B2/en not_active Ceased
- 2003-01-06 JP JP2003557275A patent/JP4545440B2/ja not_active Expired - Fee Related
- 2003-01-06 IL IL16285003A patent/IL162850A0/xx unknown
- 2003-01-06 CA CA2471147A patent/CA2471147C/en not_active Expired - Fee Related
- 2003-01-06 CN CNA038048817A patent/CN1638775A/zh active Pending
- 2003-01-06 US US10/500,694 patent/US20050143388A1/en not_active Abandoned
- 2003-01-06 EP EP03729347A patent/EP1469852A4/en not_active Withdrawn
-
2004
- 2004-07-12 ZA ZA2004/05507A patent/ZA200405507B/en unknown
-
2009
- 2009-08-04 JP JP2009181759A patent/JP2009256374A/ja active Pending
-
2010
- 2010-09-24 US US12/889,873 patent/US20120009152A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005514406A5 (https=) | ||
| Schwartz et al. | Boosting T-cell immunity as a therapeutic approach for neurodegenerative conditions: the role of innate immunity | |
| DE60336934D1 (de) | Verwendung von igf-1-serumspiegel-erhöhenden indolessigsäure-derivaten zur herstellung eines arzneimittels zur behandlung von verschiedenen krankheiten | |
| JP2022526820A (ja) | 間葉系幹細胞およびそのエクソソームによる微小血管障害の治療 | |
| Colombo et al. | Modeling hypoxia induced factors to treat pulpal inflammation and drive regeneration | |
| Wang et al. | Valproic acid labeled chitosan nanoparticles promote the proliferation and differentiation of neural stem cells after spinal cord injury | |
| JP2019142831A5 (https=) | ||
| EP2330111A3 (en) | Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases | |
| WO2022076556A3 (en) | Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 | |
| Shirzad et al. | Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine | |
| García-Ayuso et al. | Bone marrow-derived mononuclear stem cells in the treatment of retinal degenerations | |
| Xian et al. | Exosomes from adipose-derived stem cells can prevent medication-related osteonecrosis of the jaw | |
| Tan et al. | Biomaterial‐Facilitated Local Delivery of Stem Cell‐Derived Small Extracellular Vesicles: Perspectives in Surgical Therapy | |
| CN113521309B (zh) | 人肝细胞生长因子基因在湿疹治疗中的应用及微针药械 | |
| JP5334584B2 (ja) | アミノ酸とヒアルロン酸ナトリウムを基にした滅菌粉末の形態の創傷治癒医薬組成物 | |
| Fu et al. | New hope for esophageal stricture prevention: A prospective single-center trial on acellular dermal matrix | |
| CN118319980A (zh) | 一种具有皮肤再生修复作用的乌药提取物凝胶及其制备方法 | |
| CN111920827B (zh) | 促组织愈合的复方缓释纳米粒的制备方法 | |
| Nasrat et al. | Role of blood-let out cupping therapy in angina and angina risk management | |
| Soria et al. | Treatment of pyoderma gangrenosum with cyclosporin A | |
| WO2016120647A4 (en) | Muscle regeneration | |
| CN107073077B (zh) | 睫状神经营养因子鼻腔给药系统及其制备方法和应用 | |
| Keagle et al. | Bioregenerative Applications of the Human Mesenchymal Stem Cell-Derived Secretome: Part-I | |
| CN120118968A (zh) | 具有缓解肌少症作用鹿肉肽的制备方法及其缓解肌少症作用的验证方法 | |
| CN120938916A (zh) | 一种具有免疫调节及抗炎功能的鼻用温敏水凝胶及其制备方法与应用 |